Phase I clinical trials of WR-2721 with alkylating agent chemotherapy-Reference-Cited by-同舟云学术

Phase I clinical trials of WR-2721 with alkylating agent chemotherapy

Published:1982-03 Issue:3-4 Volume:8 Page:575-580
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Glick John H.,Glover Donna J.,Weiler Clare,Blumberg Albert,Nelson Diana,Yuhas John M.,Kligerman Morton

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference11 articles.

1. Clinical trials of WR-2721 with radiation therapy;Blumberg;Int. J. Radiat. Oncol. Biol. Phys.,1982

2. Phase I trials of WR-2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinum;Kligerman;Cancer Clin. Trials,1981

3. Cysteine protection against x-irradiation;Patt;Science,1949

4. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFU's by WR-2721;Wasserman;Cancer Clin. Trials,1981

5. Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine;Yuhas;Cancer Treat. Rep.,1979

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoprotective effects of amifostine in the treatment of childhood malignancies;Pediatric Blood & Cancer;2009-07-01

2. A Pilot Study of Addition of Amifostine to Melphalan, Carboplatin, Etoposide, and Cyclophosphamide With Autologous Hematopoietic Stem Cell Transplantation in Pediatric Solid Tumors–A Pediatric Blood and Marrow Transplant Consortium Study;Journal of Pediatric Hematology/Oncology;2008-03

3. Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy;Pediatric Blood & Cancer;2004

4. Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia;Cancer Chemotherapy and Pharmacology;2003-09-01

5. Negative selection and protection of normal progenitor cells for autografting;Bone Marrow Transplantation;1998-08-19